Essayer OR - Gratuit
How India's obesity drug market could boom after Mounjaro launch
Mint Ahmedabad
|March 25, 2025
It's not just for the celebrities anymore. The 'miracle' weight loss drug race has arrived in India with the launch of American drugmaker Eli Lilly's Mounjaro last week.
Priced at ₹17,500 monthly for a 5mg dose, the drug has an early-mover advantage. But it's just the start. In the coming year, India will see launches from competitors, including generics priced 90-95% lower than this.
Weight loss treatments are set to change drastically with the introduction of these blockbuster medicines.
What are these 'miracle' weight-loss drugs?
Mounjaro, an injectable drug used to treat type-2 diabetes and obesity, was launched in India last week. Chemically known as Tirzepatide, it belongs to a class of drugs known as GLP-1 (glucagon-like peptide-1) receptor agonists, which mimic the GLP-1 hormone to promote a feeling of fullness and regulate blood sugar.
Cette histoire est tirée de l'édition March 25, 2025 de Mint Ahmedabad.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Ahmedabad
Mint Ahmedabad
Trump's bets on China and Argentina are souring fast
When it comes to US foreign economic polic policy, President Donald Trump’s administration has two problems on its hands.
3 mins
November 18, 2025
Mint Ahmedabad
Centre mulls cut in PLI auto sops to ₹2,000 cr for FY26
Scheme has faced challenges including localization requirements and delays in disbursal
2 mins
November 18, 2025
Mint Ahmedabad
SGX to list Bitcoin, Ether perpetual futures on 24 Nov
Traders in SGX's perpetual futures won't automatically get liquidated if a sudden market shift upsets their positions.
2 mins
November 18, 2025
Mint Ahmedabad
Do pre-IPO gains get long-term tax status?
I live in Australia and I own shares in a Indian company which got recently listed. I invested about 1.5 years back when it was not listed. When I sell the shares now, will it be considered as shortor long-term gains? —Name withheld on request
1 mins
November 18, 2025
Mint Ahmedabad
OTTs chase regional content with higher spends but viewership trails
Platforms need carefully considers content strategies to ensure they are meeting the needs but viewership trails
1 mins
November 18, 2025
Mint Ahmedabad
India's music stardom has moved from film sets to feeds
A few verses, a guitar, and an Instagram Reel were enough to catapult Anumita Nadesan into the national spotlight.
2 mins
November 18, 2025
Mint Ahmedabad
A. Vellayan, known for visionary bets, passes away at 72
His friends and peers called Arunachalam Vellayan (72), former chairman of Murugappa group who passed away in Chennaion Monday, a man with a high level of business acumen and an ability to see the future.
1 mins
November 18, 2025
Mint Ahmedabad
Sebi has started review of listing, disclosure norms
The Securities and Exchange Board of India (Sebi) has begun work on a review of the Listing Obligations and Disclosure Requirements (LODR), its chairperson Tuhin Kanta Pandey said, setting the stage for what could be one of the regulator's most significant cleanups of corporate disclosure rules in recent years.
1 mins
November 18, 2025
Mint Ahmedabad
INSIDE AP'S NEW MANTRA: 'SPEED OF DOING BUSINESS'
Nara Lokesh is facing off against rival states and historical financial strain. Can he repeat his father's legacy?
9 mins
November 18, 2025
Mint Ahmedabad
Marico’s margin on slippery slope despite healthy demand
The Marico Ltd stock hit a new 52-week high of ₹764.65 on the NSE on Monday after its consolidated revenue surged 31% year-on-year to ₹3,482 crore in the September quarter (Q2FY26), led by broad-based growth across product categories.
1 mins
November 18, 2025
Listen
Translate
Change font size